4//SEC Filing
Schroeder Mark S 4
Accession 0001127602-25-004536
CIK 0000920148other
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 11:30 AM ET
Size
13.4 KB
Accession
0001127602-25-004536
Insider Transaction Report
Form 4
Schroeder Mark S
EVP, Pres Diagnostics & COO
Transactions
- Award
Non-qualified Stock Options
2025-02-11+7,300→ 7,300 totalExercise: $245.14From: 2026-02-11Exp: 2035-02-10→ Common Stock (7,300 underlying) - Exercise/Conversion
Restricted Stock Unit
2025-02-11−473→ 4,588 total→ Common Stock (473 underlying) - Tax Payment
Common Stock
2025-02-11$245.14/sh−134$32,849→ 6,396.143 total - Exercise/Conversion
Common Stock
2025-02-11+473→ 6,530.143 total - Award
Restricted Stock Unit
2025-02-11+2,420→ 5,061 total→ Common Stock (2,420 underlying)
Footnotes (7)
- [F1]Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
- [F2]Stock withholding to satisfy tax withholding obligations.
- [F3]Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. Amended and Restated 2016 Omnibus Incentive Plan.
- [F4]The option vested in three equal annual installments beginning on the date reflected in this column.
- [F5]The Restricted Stock Units vest in three equal annual installments beginning on February 11, 2026.
- [F6]This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
- [F7]The Restricted Stock Units vested in three equal annual installments beginning on February 11, 2023 and are now fully vested.
Documents
Issuer
LABCORP HOLDINGS INC.
CIK 0000920148
Entity typeother
Related Parties
1- filerCIK 0001793112
Filing Metadata
- Form type
- 4
- Filed
- Feb 12, 7:00 PM ET
- Accepted
- Feb 13, 11:30 AM ET
- Size
- 13.4 KB